Please provide your email address to receive an email when new articles are posted on . On-treatment improvement of MELD scores correlated with reduced risk for all-cause mortality and hepatic events ...

Liver transplant candidates may get a fairer shake from an artificial intelligence-based organ allocation system than that offered by the current Model for End-Stage Liver Disease (MELD) scoring ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patient survival was no different for living donor liver transplant recipients with a MELD score ...

Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...

During the 3-month follow up, 223 patients died. The causes of death were all related to liver disease: 49 patients died of hepatorenal syndrome; 117 patients died of hepatic encephlophy; 44 patients ...

Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...

The Model for End-stage Liver Disease (MELD) score—derived from serum total bilirubin and creatinine levels, plus the international normalized ratio—is commonly used in the US to assess patients' ...

Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in ...

Laboratory traits used in the calculation of sodium-adjusted model for end-stage liver disease (MELDNa) scores placed women at a distinct disadvantage, researchers reported. In an electronic health ...